- TheStreet.com•18 hours ago
Answering questions from the Biotech Mailbag on FLXN and SGYP.
- TheStreet.com•last month
AstraZeneca shares, meanwhile, were less-than-moved by the news.
- TheStreet.com•3 months ago
The negative investor sentiment for health care stocks in 2016 presented a particularly challenging environment to accomplish anything well. Each of these CEOs met the challenge and succeeded.
Requested symbol wasn't found